王欣之

發布者:韓婧發布時間:2025-03-24浏覽次數:10





姓名:王欣之

職稱:教授、博士生導師

E-mailxinzhiwang@njucm.edu.cn

主要研究方向:中藥(天然藥物)抗腫瘤分子機制;中藥(天然藥物)抗腫瘤新藥研發


個人簡介

王欣之,教授,博士生導師,中國藥科大學天然藥物化學博士,美國加州大學伯克利分校勞倫伯克利國家實驗室訪問學者。主要研究方向為中藥(天然藥物)抗腫瘤分子機制研究。主持多項國家級、省部級科研項目,以第一或通訊作者身份在 Cancer ResearchActa Pharmaceutica Sinica BeBioMedicineRedox Biology 等國際期刊發表論文30餘篇。現任江蘇省藥學會海洋藥物專業委員會委員。


承擔的主要科研項目

  1. 國家自然科學基金面上項目,32074067,基于SUMO化修飾調控的中藥石蟬草裂木脂素抗KRAS突變型腫瘤的作用機制研究,2021/01-2024/12,主持,55萬,結題;

  2. 江蘇省高校自然科學重大項目,24KJA360010,鹽生中藥甜瓜蒂Cucurbitacin B 抑制乳腺癌耐藥肺轉移的機制研究,2024/07-2027/07,主持,15萬,在研;

  3. 江蘇省高校自然科學重大項目,19KJA310006,菊芋倍半萜内酯抗白血病幹細胞的機制及構效關系研究,時間: 2019/09-2022/09,主持,30萬,結題;

  4. 江蘇省自然科學基金面上項目,BK20181419,Heliangolides型倍半萜内酯選擇性抗白血病幹細胞的機制及構效關系研究,2018/07-2022/07,主持,10萬,結題;

  5. 國家自然科學基金青年項目,81402812,基于分子對接技術的天然裂木脂素Peperomin E抗腫瘤靶标的尋找及結構優化研究,2015/01-2017/12,主持,23萬,結題;

  6. 江蘇省自然科學基金青年項目,BK20130954,天然産物Peperomin E誘導胃癌細胞凋亡的機制和結構修飾研究,2013/06-2016/06,20萬元,主持,結題。


代表性論文

  1. Xinzhi Wang; Yi Qu; Qianqian Xu; Zeyu Jiang; Hang Wang; Binyan Lin; Zehong Cao; Yuqi Pan; Sheng Li; Yili Hu; Hui Yang; Li He; Hang Chang; Bo Hang; Hongmei Wen; Hao Wu; Jian-Hua Mao; NQO1 Triggers Neutrophil Recruitment and NET Formation to Drive Lung Metastasis of Invasive Breast Cancer, Cancer Research, 2024, 84(21): 3538–55.(中科院1區,IF=12.5

  2. Hui Yang1; Xinzhi Wang1; Adrián Blanco-Gómez; Li He; Natalia García-Sancha; Roberto Corchado-Cobos; Manuel Jesús Pérez-Baena; Alejandro Jiménez-Navas; Pin Wang; Jamie L. Inman; Antoine M. Snijders; David W. Threadgill; Allan Balmain; Hang Chang; Jesus Perez-Losada; Jian-Hua Mao; A Susceptibility Gene Signature for ERBB2-Driven Mammary Tumour Development and Metastasis in Collaborative Cross Mice, eBioMedicine, 2024, 106: 105260.(中科院1區,IF=9.7

  3. Yin Feng; Yefan Han; Anni Hu; Yi Qu; Yili Hu; Hao Wu; Xinzhi Wang*; Li He*; Heliangin Acts as a Covalent Ligand of RPS2 That Disrupts Pre-rRNA Metabolic Processes in NPM1-Mutated Acute Myeloid Leukemia, Acta Pharmaceutica Sinica B, 2023, 13(2): 598–617.(中科院1區,IF=14.8

  4. Anni Hu; Hang Wang; Qianqian Xu; Yuqi Pan; Zeyu Jiang; Sheng Li; Yi Qu; Yili Hu; Hao Wu; Xinzhi Wang*; A Novel CPT1A Covalent Inhibitor Modulates Fatty Acid Oxidation and CPT1A-VDAC1 Axis with Therapeutic Potential for Colorectal Cancer, Redox Biology, 2023, 68: 102959.(中科院1區,IF=10.7

  5. Yefan Han; Anni Hu; Yi Qu; Qianqian Xu; Hang Wang; Yin Feng; Yili Hu; Li He; Hao Wu; Xinzhi Wang*; Covalent Targeting the LAS1-NOL9 Axis for Selective Treatment in NPM1 Mutant Acute Myeloid Leukemia, Pharmacological Research, 2023, 189: 106700.(中科院2區,IF=9.1

  6. Hui Yang1; Xinzhi Wang1; Pin Wang; Li He; Suzyann F. Schick; Peyton Jacob; Neal Benowitz; Lara A. Gundel; Chi Zhu; Yankai Xia; Jamie L. Inman; Hang Chang; Antoine M. Snijders; Jian-Hua Mao; Bo Hang; Thirdhand Tobacco Smoke Exposure Increases the Genetic Background-Dependent Risk of Pan-Tumor Development in Collaborative Cross Mice, Environment International, 2023, 174: 107876.(中科院1區,IF=10.3



  1. Xinzhi Wang; Ming Gao; Jiyun Zhang; Ying Ma; Wenshu Qu; Jingyu Liang; Hao Wu; Hongmei Wen; Peperomin E and Its Orally Bioavailable Analog Induce Oxidative Stress-Mediated Apoptosis of Acute Myeloid Leukemia Progenitor Cells by Targeting Thioredoxin Reductase, Redox Biology, 2019, 24: 101153.(中科院1區,IF=10.7





南中醫bevictor伟德官网南中醫bevictor伟德官网學子南中醫bevictor伟德官网研究生
Baidu
sogou